Successful isatuximab desensitization in a patient with refractory multiple myeloma and indolent systemic mastocytosis
J Investig Allergol Clin Immunol
.
2023 Dec 19:0.
doi: 10.18176/jiaci.0990.
Online ahead of print.
Authors
E M Hutten
1
,
W Wh Roeloffzen
2
,
A Ja Lambeck
3
,
T van den Born-Bondt
4
,
H Ng Oude Elberink
1
,
A Ajm van de Ven
1
5
Affiliations
1
Department of Internal Medicine, division of Allergology, University Medical Center Groningen, Groningen, the Netherlands.
2
Department of Hematology, University Medical Center Groningen, Groningen, the Netherlands.
3
Department of Laboratory Medicine, University Medical Center Groningen, Groningen, The Netherlands.
4
Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, Groningen, the Netherlands.
5
Department Rheumatology and Clinical Immunology, University Medical Center Groningen.
PMID:
38113126
DOI:
10.18176/jiaci.0990
No abstract available
Keywords:
Anaphylaxis; Desensitization; Isatuximab; Systemic mastocytosis.